Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Intraocular Cytokine Changes in Patients with Polypoidal Choroidal Vasculopathy Treated with Ranibizumab: Youna Choi, So Hee Kim, Seung Kwon Choi et al.; J Korean Ophthalmol Soc. 2022;63(2):166-174. Published online February 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.2.166; Full text PubReader ePub PDF

Survey of AREDS2 Formula Intake in Korean Patients with Age-related Macular Degeneration: Jeong Ho Na, Jae Wan Lim, Jong Wook Bang, Kang Yeun Pak, Hyun Woong Kim; J Korean Ophthalmol Soc. 2021;62(11):1502-1508. Published online November 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.11.1502
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration: Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(9):1218-1226. Published online September 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.9.1218
Web of Science 3 Crossref 3; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

Depression, Anxiety, Somatization Disorder, and Adjustment Disorder in Older Patients with Exudative Age-related Macular Degeneration: Hee Chul Lee, Hyewon Nam, Dongwoo Kang, Myeong In Yeom; J Korean Ophthalmol Soc. 2021;62(8):1069-1075. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1069; Full text PubReader ePub PDF

Proportion and Reasons for Ineligibility to Re-register for Extended Health Insurance in Neovascular Age-related Macular Degeneration: Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(7):948-956. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.948
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

One-year Outcomes of a Treat-and-extend of Ranibizumab for Naive Exudative Age-related Macular Degeneration: Retrospective Analysis: Young-Je Choi, Woong-Sun Yoo, Yong-Wun Cho, Yu-Jin Choi, In Young Chung; J Korean Ophthalmol Soc. 2021;62(7):939-947. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.939
Crossref 1; Full text PubReader ePub PDF

Reading Speed after Anti-vascular Endothelial Growth Factor Therapy in Patients with Wet Age-related Macular Degeneration: Tae Hwan Moon, Seungheon Lee, Jae Hyung Kim, Dong Yoon Kim, Ju Byung Chae; J Korean Ophthalmol Soc. 2021;62(1):68-76. Published online January 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.1.68
Web of Science 1 Crossref 2; Full text PubReader ePub PDF

Analyses of Risk Factors of Age-related Macular Degeneration Using Routine Health Check-up Data: Dong Kyun Han, Hong Kyu Kim; J Korean Ophthalmol Soc. 2021;62(1):46-54. Published online January 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.1.46; Full text PubReader ePub PDF

Clinical Outcomes after Switching from As-needed to Proactive Injections in the Neovascular Age-related Macular Degeneration: Soo Hyun Lim, Jae Hyung Hwang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim; J Korean Ophthalmol Soc. 2020;61(6):630-638. Published online June 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.6.630; Full text PubReader ePub PDF

Socioeconomic Costs of Age-related Macular Degeneration in Korea.: Yongsun Ahn, Donghyun Jee; J Korean Ophthalmol Soc. 2019;60(8):765-772. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.765
Web of Science 2 Crossref 5; PDF

Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):758-764. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.758
Web of Science 2 Crossref 4; PDF

Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review.: Min Joo Kang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):748-757. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.748; PDF

Prevalence of Exudative Age-related Macular Degeneration and Projections of the Cost of Ranibizumab in Korea.: Sunyoung Ryu, Dong Wook Kim, Tyler Hyungtaek Rim, Eun Jee Chung, Jiwon Kim; J Korean Ophthalmol Soc. 2019;60(3):253-260. Published online March 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.3.253
Web of Science 3 Crossref 5; PDF

Volume 67, No. 5

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

6,506	Self-assessment of Visual Acuity Using a Smartphone Application
4,603	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
3,075	Central Anticholinergic Syndrome Induced by Atropine Eye Drops: A Case Report
1,769	Efficacy of 1% Ivermectin Ointment for Demodex Blepharitis
3,253	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Cited By 4	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 2	What Laboratory Examinations for Open-angle Glaucoma Risk Stratification
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens
Cited By 2	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next